SIP
RCEL icon

Stoneridge Investment Partners’s Avita Medical RCEL Stock Holding History

Stoneridge Investment Partners’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,719
Closed -$51K – 183
2026
Q1 		$51K Hold
13,719
– – 0.04% 126
2025
Q4 		$47K Buy
+13,719
New +$54.7K 0.03% 123

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Stoneridge Investment Partners's RCEL Position: Q2 2026 in Review

Stoneridge Investment Partners sold out of Avita Medical (RCEL) in Q2 2026, closing a stake of 13,719 shares — an estimated $51K sold.

Stoneridge Investment Partners first reported a position in RCEL in Q4 2025 and held it in 2 quarters. The position peaked at $51K in Q1 2026. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Stoneridge Investment Partners reported no remaining Avita Medical position as of Q2 2026 after selling out during the quarter.
  • Stoneridge Investment Partners sold 13,719 Avita Medical shares in Q2 2026, an estimated $51K.
  • Stoneridge Investment Partners first reported a position in Avita Medical in Q4 2025 and held it in 2 quarters.
  • Stoneridge Investment Partners's Avita Medical position peaked at $51K in Q1 2026.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Stoneridge Investment Partners's 13F filing for Q2 2026, filed 6 Aug 2026.